These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25975658)

  • 1. The perils of surrogate endpoints.
    Weintraub WS; Lüscher TF; Pocock S
    Eur Heart J; 2015 Sep; 36(33):2212-8. PubMed ID: 25975658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update diabetes mellitus and cardiovascular diseases].
    Otter W
    MMW Fortschr Med; 2012 Apr; 154(7):95-8. PubMed ID: 22558884
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of serum cholesterol and cholesterol subfractions on restenosis following successful coronary intervention.
    Violaris AG; Ismail TF; El-Gendi H; Foale RA
    Semin Interv Cardiol; 1999 Sep; 4(3):111-9. PubMed ID: 10545617
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy and clinical trials: beyond low-density lipoprotein cholesterol reduction.
    Bhattacharya S
    Curr Opin Lipidol; 2006 Dec; 17(6):708-12. PubMed ID: 17095918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative].
    Assmann G
    Fortschr Med; 1991 Jun; 109(17):361-3. PubMed ID: 1885117
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of diabetes in cardiovascular patients: diabetic heart disease.
    Peter R; Cox A; Evans M
    Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent trials of lipid lowering.
    Ray KK; Cannon CP; Braunwald E
    Int J Clin Pract; 2007 Jul; 61(7):1145-59. PubMed ID: 17577297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular complications of renal disease.
    Jardine AG; McLaughlin K
    Heart; 2001 Oct; 86(4):459-66. PubMed ID: 11559693
    [No Abstract]   [Full Text] [Related]  

  • 10. The ADVANCE trial: further PROGRESS with HOPE.
    Karthikeyan VJ; Bakris G; MacFadyen RJ
    J Hum Hypertens; 2007 Dec; 21(12):911-3. PubMed ID: 17960167
    [No Abstract]   [Full Text] [Related]  

  • 11. Intervening on HDL-C: is it possible? Does it work?
    Wierzbicki AS
    Int J Clin Pract; 2007 Nov; 61(11):1782-6. PubMed ID: 17935541
    [No Abstract]   [Full Text] [Related]  

  • 12. New frontiers in cardiovascular care. Better devices, targeted drugs, tests, home monitoring are on the way.
    Heart Advis; 2005 May; 8(5):1, 7. PubMed ID: 16138395
    [No Abstract]   [Full Text] [Related]  

  • 13. High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise.
    Harv Heart Lett; 2012 Sep; 23(1):6. PubMed ID: 23097807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pre-treatment of risk patients with cardiovascular disorders].
    Bonhoeffer K; Kämmerer H
    Klin Anasthesiol Intensivther; 1976 Apr; (11):123-9. PubMed ID: 62865
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of HDL and LDL cholesterol for prevalent coronary calcification.
    Allison MA; Wright CM
    Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?
    Schaefer EJ
    Curr Opin Lipidol; 2013 Jun; 24(3):259-64. PubMed ID: 23652567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review.
    Brouwer IA; Wanders AJ; Katan MB
    PLoS One; 2010 Mar; 5(3):e9434. PubMed ID: 20209147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and metabolic profile in diabetic cardiovascular disease.
    Vaishnava H; Hagroo AA
    J Indian Med Assoc; 1973 Aug; 61(4):159-66. PubMed ID: 4590355
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of quality of life in clinical trials of cardiovascular therapies.
    Wenger NK; Mattson ME; Furberg CD; Elinson J
    Am J Cardiol; 1984 Oct; 54(7):908-13. PubMed ID: 6333175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.